NPI: 1356716575 · HORSE CAVE, KY 42749 · Certified Registered Nurse Anesthetist · NPI assigned 12/14/2015
Authorized official LAWLESS, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWLESS, MICHELE (EXECUTIVE VICE PRESIDENT/CFO) |
| NPI Enumeration Date | 12/14/2015 |
Other providers sharing the same authorized official: LAWLESS, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 32,404 | $1.69M |
| 2019 | 33,155 | $1.52M |
| 2020 | 31,821 | $1.80M |
| 2021 | 35,729 | $2.14M |
| 2022 | 34,303 | $2.11M |
| 2023 | 36,330 | $2.25M |
| 2024 | 26,773 | $1.95M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 11,006 | 9,052 | $3.35M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 11,213 | 9,796 | $2.16M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,235 | 2,822 | $1.49M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,144 | 1,763 | $1.01M |
| 70450 | Computed tomography, head or brain; without contrast material | 1,666 | 1,265 | $522K |
| 36415 | Collection of venous blood by venipuncture | 38,918 | 15,967 | $357K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5,717 | 1,119 | $323K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 272 | 247 | $322K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,976 | 3,456 | $287K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,173 | 4,604 | $256K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,457 | 2,925 | $244K |
| 71046 | Radiologic examination, chest; 2 views | 3,122 | 2,526 | $242K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,510 | 1,397 | $216K |
| 80053 | Comprehensive metabolic panel | 20,187 | 12,954 | $194K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,208 | 2,232 | $183K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,402 | 1,265 | $175K |
| 71045 | Radiologic examination, chest; single view | 3,076 | 2,429 | $156K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,561 | 14,384 | $127K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,406 | 2,864 | $123K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,890 | 1,583 | $98K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,116 | 2,826 | $97K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 490 | 444 | $77K |
| 84443 | Thyroid stimulating hormone (TSH) | 5,086 | 4,647 | $76K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 982 | 927 | $74K |
| 72100 | 810 | 642 | $72K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 782 | 644 | $72K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,518 | 2,234 | $65K |
| 80061 | Lipid panel | 3,736 | 3,357 | $58K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 702 | 649 | $49K |
| J7050 | Infusion, normal saline solution, 250 cc | 3,445 | 1,742 | $48K |
| 73630 | 487 | 397 | $47K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,624 | 1,381 | $45K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,408 | 1,126 | $42K |
| 73030 | 437 | 316 | $40K | |
| 82607 | 2,818 | 2,555 | $38K | |
| 80306 | 2,452 | 2,129 | $35K | |
| 84484 | 3,164 | 2,606 | $33K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1,021 | 65 | $30K |
| 73610 | 297 | 249 | $29K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,417 | 2,901 | $29K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,231 | 1,018 | $29K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 266 | 210 | $28K |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,208 | 1,349 | $27K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 499 | 461 | $26K |
| 73562 | 242 | 166 | $24K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,775 | 1,422 | $24K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,824 | 2,612 | $23K |
| 84703 | 2,843 | 2,518 | $23K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,896 | 2,217 | $21K |
| 71250 | 74 | 53 | $20K | |
| 83690 | 2,894 | 2,524 | $20K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 294 | 240 | $20K |
| 73130 | 190 | 153 | $19K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,936 | 1,943 | $19K |
| 87081 | 1,516 | 1,269 | $14K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,120 | 890 | $14K |
| 81003 | 2,975 | 2,580 | $14K | |
| 82746 | 1,099 | 996 | $14K | |
| 74018 | 135 | 124 | $13K | |
| 83880 | 436 | 365 | $12K | |
| 81001 | 2,437 | 2,079 | $10K | |
| 84439 | 1,362 | 1,216 | $10K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 581 | 489 | $10K |
| 87631 | 82 | 75 | $9K | |
| 83605 | 879 | 762 | $9K | |
| 72040 | 84 | 63 | $9K | |
| G0378 | Hospital observation service, per hour | 40 | 25 | $8K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 599 | 392 | $8K |
| 83735 | 1,420 | 1,146 | $8K | |
| 82553 | 567 | 473 | $7K | |
| 82550 | 907 | 758 | $6K | |
| 82728 | 494 | 434 | $6K | |
| 85610 | 1,655 | 1,407 | $6K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 414 | 287 | $5K |
| 95886 | 32 | 27 | $5K | |
| 81015 | 1,137 | 1,031 | $5K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 528 | 298 | $4K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 231 | 185 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 150 | 53 | $4K |
| 82150 | 523 | 466 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 96 | 24 | $3K |
| 73110 | 36 | 26 | $3K | |
| 90715 | 109 | 105 | $3K | |
| 85730 | 558 | 472 | $3K | |
| 85379 | 254 | 228 | $3K | |
| 87040 | 116 | 97 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 14 | 14 | $2K |
| 94664 | 126 | 79 | $2K | |
| 80074 | 29 | 26 | $2K | |
| 83540 | 324 | 296 | $2K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 98 | 88 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 44 | 28 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 23 | 21 | $2K |
| 87186 | 189 | 158 | $1K | |
| 83550 | 167 | 149 | $1K | |
| J3490 | Unclassified drugs | 109 | 78 | $1K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 63 | 15 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 57 | 39 | $1K |
| 86140 | 151 | 129 | $727.93 | |
| L4387 | Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf | 13 | 13 | $720.00 |
| 82948 | 68 | 52 | $656.68 | |
| J2704 | Injection, propofol, 10 mg | 19 | 14 | $535.40 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 30 | 26 | $462.17 |
| 87088 | 61 | 50 | $448.55 | |
| 80050 | General health panel | 17 | 13 | $441.51 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 34 | 32 | $440.04 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 19 | 14 | $296.26 |
| 85651 | 83 | 67 | $271.18 | |
| 82043 | 48 | 39 | $227.60 | |
| 82570 | 14 | 14 | $80.75 | |
| 3044F | 27 | 21 | $58.23 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 13 | 12 | $0.05 |